Effect of HIV and substance use disorder comorbidity on the placenta, fetal and maternal health outcomes: systematic review and meta-analysis protocol

被引:1
|
作者
Sorato, Mende Mensa [1 ]
Alemu, Tsegaye [2 ]
Toma, Alemayehu [1 ]
Paulos, Getahun [1 ]
Mekonnen, Shewangizaw [3 ]
机构
[1] Komar Univ Sci & Technol, Sch Med, Pharm, Sulaymania, Iraq
[2] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia
[3] Komar Univ Sci & Technol, Sch Med, Nursing, Sulaymania, Iraq
来源
BMJ OPEN | 2024年 / 14卷 / 05期
关键词
HIV & AIDS; substance misuse; maternal medicine; fetal medicine; DATA-COLLECTION; CASE-DEFINITION; PREGNANCY; GUIDELINES; INFECTION; WOMEN;
D O I
10.1136/bmjopen-2023-083037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Substance use disorders and HIV infection have a bidirectional relationship. People who use illicit drugs are at increased risk of contracting HIV/AIDS, and people living with HIV/AIDS are at increased risk of using substances due to disease-related complications like depression and HIV-associated dementia. There is no adequate evidence on the effect of HIV/AIDS and substance use disorder comorbidity-related effects on placental, fetal, maternal and neonatal outcomes globally. Methods and analysis We will search articles written in the English language until 30 January 2024, from PubMed/Medline, Cochrane Library, Embase, Scopus, Web of Sciences, SUMsearch2, Turning Research Into Practice database and Google Scholar. A systematic search strategy involving AND/OR Boolean Operators will retrieve information from these databases and search engines. Qualitative and quantitative analysis methods will be used to report the effect of HIV/AIDS and substance use disorders on placental, fetal and maternal composite outcomes. Descriptive statistics like pooled prevalence mean and SD will be used for qualitative analysis. However, quantitative analysis outcomes will be done by using Comprehensive Meta-Analysis Software for studies that are combinable. The individual study effects and the weighted mean difference will be reported in a forest plot. In addition to this, the presence of multiple morbidities like diabetes, chronic kidney disease and maternal haemoglobin level could affect placental growth, fetal growth and development, abortion, stillbirth, HIV transmission and composite maternal outcomes. Therefore, subgroup analysis will be done for pregnant women with multiple morbidities. Ethics and dissemination Since systematic review and meta-analysis will be conducted by using published literature, ethical approval is not required. The results will be presented in conferences and published in peer-reviewed journals.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: a systematic review and meta-analysis
    Wei Huang
    Teng Wu
    Tianyu Jin
    Yuan Zhang
    Jing Wang
    Jiaping Qi
    Yixuan Li
    Huan Jiang
    Ju Zhang
    Zhaoyu Jiang
    Lin Chen
    Zhenhua Ying
    Clinical Rheumatology, 2023, 42 : 855 - 870
  • [32] Maternal and fetal outcomes in Latin American SLE pregnancies: A systematic review and meta-analysis
    Cajamarca-Baron, Jairo
    Sanmiguel-Reyes, Catalina
    Bedoya-Loaiza, Juan Esteban
    Castaneda-Gonzalez, Juan Pablo
    Acelas-Gonzalez, Gabriel E.
    Molina-Giraldo, Saulo
    Guavita-Navarro, Diana
    Ibanez, Claudia
    Escobar, Alejandro
    Rojas-Villarraga, Adriana
    AUTOIMMUNITY REVIEWS, 2025, 24 (04)
  • [33] Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: a systematic review and meta-analysis
    Huang, Wei
    Wu, Teng
    Jin, Tianyu
    Zhang, Yuan
    Wang, Jing
    Qi, Jiaping
    Li, Yixuan
    Jiang, Huan
    Zhang, Ju
    Jiang, Zhaoyu
    Chen, Lin
    Ying, Zhenhua
    CLINICAL RHEUMATOLOGY, 2023, 42 (03) : 855 - 870
  • [34] Systematic Review and Meta-Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder
    Fluyau, Dimy
    Revadigar, Neelambika
    Pierre, Christopher G.
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (02): : 110 - 121
  • [35] Biologic use during conception and pregnancy and its impact on fetal and maternal outcomes: systematic review and meta-analysis
    O'Byrne, L.
    Alqatari, S.
    O'Sullivan, A.
    Maher, G.
    Khashan, A.
    Murphy, G.
    McCarthy, F.
    HUMAN REPRODUCTION, 2022, 37 : I368 - I368
  • [36] Mindfulness for internet use disorder: a study protocol of a systematic review and meta-analysis
    Fendel, Johannes Caspar
    Schmidt, Stefan
    BMJ OPEN, 2022, 12 (09):
  • [37] Effect of maternal obsessive-compulsive disorder (OCD) on feto-maternal outcomes: A systematic review and meta-analysis
    Aujla, Savvy
    Sandeep, Mokanpally
    Aparnavi, Periasamy
    Padhi, Bijaya Kumar
    Shamim, Muhammad Aaqib
    Sahoo, Swapnajeet
    Gangane, Neha
    Gandhi, Aravind P.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 167 (03) : 949 - 956
  • [38] Treatment for substance use disorder in mothers of young children: A systematic review of maternal substance use and child mental health outcomes
    Joyce, Kayla M.
    Delaquis, Chantal P.
    Alsaidi, Tia
    Sulymka, Julia
    Conway, Alexandra
    Garcia, Juanita
    Paton, Allyson
    Kelly, Lauren E.
    Roos, Leslie E.
    ADDICTIVE BEHAVIORS, 2025, 163
  • [39] Pregnancy outcomes following maternal macrolide use: A systematic review and meta-analysis
    Keskin-Arslan, Elif
    Erol, Hilal
    Uysal, Nusrel
    Karadas, Baris
    Temiz, Tijen
    Kaplan, Yusuf Cem
    REPRODUCTIVE TOXICOLOGY, 2023, 115 : 124 - 146
  • [40] The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis
    Wilson, Jack
    Langcake, Andrew
    Bryant, Zachary
    Freeman, Tom P.
    Leung, Janni
    Chan, Gary C. K.
    Englund, Amir
    Graham, Myfanwy
    Stockings, Emily
    SYSTEMATIC REVIEWS, 2025, 14 (01)